AFS ON DEMAND

We are pleased to provide on demand access to the following select sessions from the 2026 AF Symposium.

Stroke Risk Management in Atrial Fibrillation Session I

Moderators: John Day, MD and Andrea Russo, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Factor XI and XIa Inhibition for Stroke Prevention in AF: OCEANIC-AF, AZALEA, and Other Studies
Marc Sabatine, MD, MPH

Management of Device-Detected AF: Will ARTESIA and NOAH-AFNET 6 Change Current Guidelines?
Rod Passman, MD

LAA Closure in Patients with Prior Hemorrhagic or Anticoagulant-Resistant Ischemic Strokes - Update from Clinical Trials and Registries
James Freeman, MD, MPH

LAA Closure Compared to Medical Therapy in Patients with AF (CLOSURE-AF Trial)
Thorsten Lewalter, MD

Optimal Anticoagulation and Follow-up Strategies after LAA Closure
Jonathan Hsu, MD

Panel and Audience Discussion (25 minutes) – All Faculty and Rui Providencia, MD, PhD

VIEW VIDEO

Stroke Risk Management in Atrial Fibrillation Session II

Supported by an Educational Grant from Boston Scientific
Moderators: Christopher Ellis, MD and Kevin Heist, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Patient Selection for Concomitant PVI and LAA Closure - Applying OPTION to Clinical Practice
Christopher Ellis, MD

Discontinuation of Anticoagulation After Catheter Ablation for AF: ALONE-AF Trial
Boyoung Joung, MD

Discontinuation of Anticoagulation After Catheter Ablation for AF: OCEAN Trial
Atul Verma, MD

Pre, Intra, and Post-Procedural Imaging for LAA Closure - Role of TEE, ICE, & CT
Shephal Doshi, MD

New Technologies for Left Atrial Appendage Closure
Vivek Reddy, MD

Panel and Audience Discussion (25 minutes) - All Faculty

VIEW VIDEO

New Trends in Prediction and Risk Factor Modification for AF

Moderators: Mina Chung, MD and Nassir Marrouche, MD
All lectures 7 minutes. Panel and Audience Discussion 25 minutes.

Predicting Risk for Atrial Fibrillation in the Era of Artificial Intelligence
Shaan Khurshid, MD, MPH

Impact of Lifestyle and Risk Factor Modification on AF and AF Ablation Outcomes
Andrea Russo, MD

Role of GLP-1 RA on AF and AF Ablation Outcomes
Gianluca Iacobellis, MD, PhD

Current Status and Future Role of Genetics in the Management of AF
Mina Chung, MD

Integrating Wearables into Clinical Trials and Electrophysiology Practice
Jason Andrade, MD

Panel and Audience Discussion (25 minutes)

VIEW VIDEO

Endpoints and Outcomes of Catheter Ablation for Atrial Fibrillation

Moderators: Meleze Hocini, MD and Claudio Tondo, MD, PhD
All lectures 7 minutes. Panel Discussion 25 minutes.

Long-Term Outcomes of Catheter Ablation for AF in Patients with Heart Failure
Nassir Marrouche, MD

Duration, Burden and Timing of AF Recurrences after AF Ablation - Insights from Implantable Monitoring
Laurent Macle, MD

Optimal Blanking Period After Pulsed Field Ablation for Atrial Fibrillation
Luigi Di Biase, MD, PhD

Autonomic Modulation to Improve AF Ablation Outcomes
William Whang, MD

Atrial Fibrillation Mapping - Impact on Ablation Outcomes
Pierre Jais, MD

Panel and Audience Discussion (25 minutes) - All Faculty and Rui Providencia, MD, PhD

VIEW VIDEO